These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 10903323)
1. Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation. Verrecchia F; Pessah M; Atfi A; Mauviel A J Biol Chem; 2000 Sep; 275(39):30226-31. PubMed ID: 10903323 [TBL] [Abstract][Full Text] [Related]
2. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-beta in rat hepatocytes. role of phosphatidylinositol 3-kinase-induced AP-1 activation. Peron P; Rahmani M; Zagar Y; Durand-Schneider AM; Lardeux B; Bernuau D J Biol Chem; 2001 Mar; 276(13):10524-31. PubMed ID: 11134003 [TBL] [Abstract][Full Text] [Related]
4. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts. Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252 [TBL] [Abstract][Full Text] [Related]
5. A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. Verrecchia F; Tacheau C; Wagner EF; Mauviel A J Biol Chem; 2003 Jan; 278(3):1585-93. PubMed ID: 12426318 [TBL] [Abstract][Full Text] [Related]
6. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation. Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315 [TBL] [Abstract][Full Text] [Related]
8. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis. Yamamura Y; Hua X; Bergelson S; Lodish HF J Biol Chem; 2000 Nov; 275(46):36295-302. PubMed ID: 10942775 [TBL] [Abstract][Full Text] [Related]
9. Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts. Quan T; He T; Voorhees JJ; Fisher GJ J Biol Chem; 2005 Mar; 280(9):8079-85. PubMed ID: 15579469 [TBL] [Abstract][Full Text] [Related]
10. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984 [TBL] [Abstract][Full Text] [Related]
11. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts. Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687 [TBL] [Abstract][Full Text] [Related]
12. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. Higashi K; Inagaki Y; Fujimori K; Nakao A; Kaneko H; Nakatsuka I J Biol Chem; 2003 Oct; 278(44):43470-9. PubMed ID: 12917425 [TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase/activator protein-1 activation. Wendling J; Marchand A; Mauviel A; Verrecchia F Mol Pharmacol; 2003 Sep; 64(3):707-13. PubMed ID: 12920208 [TBL] [Abstract][Full Text] [Related]
15. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. Verrecchia F; Chu ML; Mauviel A J Biol Chem; 2001 May; 276(20):17058-62. PubMed ID: 11279127 [TBL] [Abstract][Full Text] [Related]
17. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. Selvamurugan N; Kwok S; Partridge NC J Biol Chem; 2004 Jun; 279(26):27764-73. PubMed ID: 15084595 [TBL] [Abstract][Full Text] [Related]
18. Involvement of MAP kinase cascades in Smad7 transcriptional regulation. Uchida K; Suzuki H; Ohashi T; Nitta K; Yumura W; Nihei H Biochem Biophys Res Commun; 2001 Nov; 289(2):376-81. PubMed ID: 11716483 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. Tardif G; Reboul P; Dupuis M; Geng C; Duval N; Pelletier JP; Martel-Pelletier J J Rheumatol; 2001 Jul; 28(7):1631-9. PubMed ID: 11469472 [TBL] [Abstract][Full Text] [Related]
20. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion. Sundqvist A; Zieba A; Vasilaki E; Herrera Hidalgo C; Söderberg O; Koinuma D; Miyazono K; Heldin CH; Landegren U; Ten Dijke P; van Dam H Oncogene; 2013 Aug; 32(31):3606-15. PubMed ID: 22926518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]